EQUITY RESEARCH MEMO

Cranial Technologies

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Cranial Technologies is a leading provider of non-surgical treatment for infant positional plagiocephaly (flat head syndrome). Founded in 1986, the company designs and manufactures custom cranial remolding orthoses (helmets) and operates a network of clinical locations across the United States, offering a direct-to-patient service model. With a focus on early intervention, the company has established itself as a key player in pediatric orthopedic care. Its vertically integrated approach—from design to fitting—ensures high-quality outcomes and patient satisfaction. The company's revenue is driven by insurance reimbursements and out-of-pocket payments, benefiting from rising awareness of plagiocephaly and recommendations from pediatricians. Cranial Technologies continues to expand its clinic footprint and explore digital innovations to streamline patient assessment and helmet fitting.

Upcoming Catalysts (preview)

  • 2026Expansion into New Geographic Markets70% success
  • 2026Launch of Telehealth or Digital Scanning Solutions50% success
  • TBDPublication of New Clinical Data Supporting Helmet Efficacy40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)